| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G | Report | 13G PHAT 10312024 | Nov 4, 2024 | |
| SC 13G | Report | Oct 21, 2024 | ||
| SC 13G/A | Report | SC 13G/A | Feb 12, 2024 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 9, 2024 | |
| SC 13G/A | Report | SC 13G/A | Jan 26, 2024 | |
| SC 13G | Report | SC 13G | Mar 9, 2023 | |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | Feb 10, 2023 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 9, 2023 | |
| SC 13G/A | Report | JHG PLC OWNS <5% | Feb 9, 2023 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 2, 2023 | |
| SC 13G/A | Report | SC 13G/A | Jan 31, 2023 | |
| SC 13G | Report | Sep 23, 2022 | ||
| SC 13G/A | Report | SC 13G/A | May 16, 2022 | |
| SC 13G/A | Report | PHATHOM PHARMACEUTICALS, INC. | Feb 14, 2022 | |
| SC 13G | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | JANUS HENDERSON GROUP PLC OWNS >5% | Feb 10, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 10, 2022 | |
| SC 13G | Report | SCHEDULE 13G | Feb 10, 2022 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 10, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2021 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 12, 2021 | |
| SC 13G/A | Report | JANUS HENDERSON GROUP PLC OWNS 6.7% | Feb 11, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 11, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 11, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2020 | |
| SC 13G | Report | JANUS HENDERSON GROUP PLC OWNS 6% OF PHATHOM | Feb 14, 2020 | |
| SC 13G | Report | SEC SCHEDULE 13G | Feb 13, 2020 | |
| SC 13G | Report | SC 13G | Feb 10, 2020 | |
| SC 13G | Report | SC 13G | Feb 10, 2020 | |
| SC 13G | Report | SC 13G | Feb 10, 2020 | |
| SC 13G | Report | SC 13G | Nov 8, 2019 |